CCR11 is a Functional Receptor for the Monocyte Chemoattractant Protein Family of Chemokines
Overview
Authors
Affiliations
Chemokines mediate their diverse activities through G protein-coupled receptors. The human homolog of the bovine orphan receptor PPR1 shares significant similarity to chemokine receptors. Transfection of this receptor into murine L1.2 cells resulted in responsiveness to monocyte chemoattractant protein (MCP)-4, MCP-2, and MCP-1 in chemotaxis assays. Binding studies with radiolabeled MCP-4 demonstrated a single high affinity binding site with an IC(50) of 0.14 nM. As shown by competition binding, other members of the MCP family also recognized this receptor. MCP-2 was the next most potent ligand, with an IC(50) of 0.45 nM. Surprisingly, eotaxin (IC(50) = 6.7 nM) and MCP-3 (IC(50) = 4.1 nM) bind with greater affinity than MCP-1 (IC(50) = 10.7 nM) but only act as agonists in chemotaxis assays at 100-fold higher concentrations. Because of high affinity binding and functional chemotactic responses, we have termed this receptor CCR11. The gene for CCR11 was localized to human chromosome 3q22, which is distinct from most CC chemokine receptor genes at 3p21. Northern blot hybridization was used to identify CCR11 expression in heart, small intestine, and lung. Thus CCR11 shares functional similarity to CCR2 because it recognizes members of the MCP family, but CCR11 has a distinct expression pattern.
Progeria and Aging-Omics Based Comparative Analysis.
Caliskan A, Crouch S, Giddins S, Dandekar T, Dangwal S Biomedicines. 2022; 10(10).
PMID: 36289702 PMC: 9599154. DOI: 10.3390/biomedicines10102440.
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease.
She S, Ren L, Chen P, Wang M, Chen D, Wang Y Front Immunol. 2022; 13:812431.
PMID: 35281057 PMC: 8913720. DOI: 10.3389/fimmu.2022.812431.
Gene Structure Analysis of Chemokines and Their Receptors in Allotetraploid Frog, .
Fukui A, Matsunami M Front Genet. 2022; 12:787979.
PMID: 35126458 PMC: 8811506. DOI: 10.3389/fgene.2021.787979.
MCP-1 targeting: Shutting off an engine for tumor development.
Wang L, Lan J, Tang J, Luo N Oncol Lett. 2021; 23(1):26.
PMID: 34868363 PMC: 8630816. DOI: 10.3892/ol.2021.13144.
Eguchi R, Karim M, Hu P, Sato T, Ono N, Kanaya S BMC Bioinformatics. 2018; 19(1):264.
PMID: 30005591 PMC: 6043997. DOI: 10.1186/s12859-018-2251-x.